Home > Consultants >
Miss Monika Kaushik
MBBS, DNB, MRCS, MD, FRCS
Consultant Breast Surgeon
GMC number: 6025668
Special interests:
Nipple and areolar surgery, Oncoplastic breast surgery, Breast cancer, Breast lumps, Breast Pain, Nipple discharge, Breast reconstruction, Risk reducing breast surgery, Revision breast surgery, Breast augmentation, Breast reduction
Miss Monika Kaushik is a highly esteemed and experienced consultant oncoplastic and breast surgeon at King Edward VII’s Hospital. Miss Kaushik specialises in breast cancer diagnosis and treatment, cosmetic breast surgery, breast reconstruction and corrective surgery as well as various benign breast-related conditions, but to mention a few.
She currently practices privately at various hospitals in Leicestershire, Nottinghamshire, and in London at King Edward VII’s Hospital. She is also working at the University Hospitals of Leicester NHS Trust since her appointment as consultant oncoplastic and breast surgeon in 2013.
Miss Kaushik’s main areas of clinical interests are: modern management of breast cancer; having a holistic approach. She has obtained a substantial amount of experience in relation to various breast-related surgical procedures, including skin and nipple sparing mastectomies, therapeutic mammoplasties, breast augmentation, breast reduction, nipple reconstruction, risk-reducing breast surgery, as well as sentinel lymph node biopsy to name a few.
Miss Kaushik actively and willingly engages herself in various medical research trials, on both a national and local level, with her main areas of research interest being axiliary treatment in breast cancer, breast cancer predictive and prognostic markers, neoadjuvant therapy in breast cancer, as well as seeking to improve surgical outcomes in oncoplastic breast surgery.
She also holds various roles in education and management, and is also a member of the Advisory Committee of Spire Nottingham Hospital. She is certified and registered by Royal College of Surgeons to practice breast cosmetic surgery.
Treatments offered at King Edward VII’s Hospital include, but are not limited to:
- Mastectomy
- Core Biopsy
- Breast Reconstruction Surgery
- Breast Augmentation Surgery
- Mastopexy
- Breast Reduction Surgery
- Lumpectomy
- Nipple Reconstruction Surgery
Miss Kaushik is a highly experienced breast surgeon known for her holistic, multidisciplinary approach and commitment to evidence-based practice.
COVID-19 Specific Projects / Groups
Ms Kaushik completed a study which she presented at a National Conference – ‘The Effects of the COVID-19 pandemic on Breast Cancer Services at a tertiary University Hospital’
Career Highlights
Miss Kaushik states her biggest success is the compliments and positive feedback from my patients. In addition, she hold various Educational and Senior Management Posts including Research Lead.
Awards
Nominated for ‘Outstanding Contribution in Clinical Practice Award’ in the NHS, July 2024
Memberships
Board member for the Medical Advisory Committee at Spire Nottingham Hospital
Royal College of Surgeons
Association of Breast Surgeons
Training Positions
Miss Kaushik trains consultants who have returned after a long period of leave. She also trained and supervised Consultants for Perforator flaps and Pre-pectoral implant reconstruction
Cutting Edge Technologies
She has had a large number of patient cohort who have had a pre-pectoral reconstruction with good outcomes. Accomplished in reconstruction using a perforator flap (which can help reduce chances of a mastectomy)
Publications
- An optimised patient derived explant platform for breast cancer refects clinical responses to chemotherapy and antibody directed therapy
http://www.nature.com/scientificreports. (2024) 14:12833 - ‘PartBreCon’ study. A UK multicentre retrospective cohort study to assess outcomes following PARTial BREast reCONstruction with chest wall perforator flaps
The Breast: Volume 71, October 2023, Pages 82-88 - Axillary sentinel lymph node identification using supermagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial ( SMART study)
The Surgeon 21 ( 2023), Issue 2 p128-134 - The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making
European Journal of Surgical OncologyVol. 48Issue 7p1510–1519Published online: April 4, 2022 - Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study
Breast Cancer Res Treat . 2023 Jun;199(2):265-279. doi: 10.1007/s10549-023-06893-4. Epub 2023 Apr 3 - External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort ( Collaborator)
Front Oncol . 2020 Oct 30;10:575909. doi: 10.3389/fonc.2020.575909. eCollection 2020. - REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer (Collaborator)
Radiother Oncol
. 2019 Sep;138:59-67. doi: 10.1016/j.radonc.2019.04.034. Epub 2019 May 27 - The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study ( Collaborator)
Br J Cancer . 2019 Apr;120(9):883-895. doi: 10.1038/s41416-019-0438-1. Epub 2019 Mar 29 - Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity ( Collaborator)
Radiother Oncol . 2021 Jun;159:241-248. doi: 10.1016/j.radonc.2021.03.024. Epub 2021 Apr 8 - Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction ( Collaborator)
Br J Surg . 2020 Jun;107(7):832-844. doi: 10.1002/bjs.11468. Epub 2020 Feb 19 - Multicentre prospective observational study evaluating recommendations for mastectomy by multidisciplinary teams
Mastectomy Decisions Audit (MasDA) Collaborative, on behalf of the West Midlands Research Collaborative ( Collaborator)
Br J Surg . 2020 Feb;107(3):227-237. doi: 10.1002/bjs.11383. Epub 2019 Nov 5 - Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer : The UK SentiMag trial ( SMART study)
The Surgeon, Volume 21, Issue 2, April 2023, 128-134 - Identification Using Superparamagnetic Iron Oxide Versus Radioisotope in Early Stage Breast Cancer: The UK SentiMag Trial (SMART Study) . Cureus (): e. doi:10.7759/cureus.
- A Prospective, single – arm, multicenter clinical evaluation of a new localization technique using non’radioactive magseeds for surgery of clinically occult breast lesions
Clin Radiol 2019 Dec;74(12):974.e7-974.e11 - S. Puri, N. Sharma, R.G. Newcombe, M. Kaushik, M. Al-Attar,
S. Pascaline, M. Hajaj, M.G. Wallis, B. Elsberger, A. Goyal
Axillary tumour burden in women with one abnormal node on ultrasound compared to
women with multiple abnormal nodes
Clinical Radiology (2017), https://doi.org/10.1016/j.crad.2017.12.014 - Oliveira-Cunha M, S Shokuhi, Kaushik M
Male Breast Cancer – Single centre experience and current evidence
The Breast Journal 2014: 20(6)674
Need further help or advice?
Contact our team for enquiries or information.
Call 020 7467 3221
Our helpful team are available Mon - Fri - 8am – 6pm. If you need to contact us in any other way, please Contact Us